Furthermore, Grp94 participated in the regulation of ER-α36 (a variant of ER-α) expression levels, and its overexpression in BC was implicated in mechanisms of resistance to chemotherapeutic drugs [101]. This evidence concerns the gene ESR1 and breast cancer.